Skip to content

Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure

Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04629014
Enrollment
750
Registered
2020-11-16
Start date
2020-02-27
Completion date
2029-12-01
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Intestinal Failure

Keywords

intestinal failure, short bowel syndrome, short gut syndrome, parenteral nutrition, specialized nutrition

Brief summary

This study proposes to quantify and describe the quality of life of children with intestinal failure, and to identify the medical and socio-economic factors that impact this quality of life, using data from multiple multidisciplinary intestinal failure centers across the United States and Canada specializing in the care of these participants.

Detailed description

Health related quality of life is becoming an increasingly important topic as medical advancements continue to increase life expectancies in various illnesses. Quality of life (QoL) encompasses the physical, psychological, and social well-being of a person. Studies focusing on health related QoL show that providers have a limited understanding of the QoL of their patients, demonstrating a need for further research. Mortality rates in pediatric intestinal failure (PIF) have significantly dropped over the past 3-4 decades and long-term morbidity rather than survival has come into focus as the outcome of interest. However, there remains a significant knowledge gap regarding the specific factors that contribute to QoL among PIF patients and their families. Insight into the challenges these patients face can promote enhanced support services and psycho-education for caregivers of these children as well as help to tailor medical and surgical treatment with a focus on improved QoL. Due to the rare nature of PIF, and despite a recent bloom in multidisciplinary PIF centers, experience is limited in individual centers and a multi-site study with a robust and diverse patient population is optimal to study QoL in pediatric intestinal failure.

Interventions

None listed

Sponsors

Boston Children's Hospital
Lead SponsorOTHER
Seattle Children's Hospital
CollaboratorOTHER
University of Alabama at Birmingham
CollaboratorOTHER
Ann & Robert H Lurie Children's Hospital of Chicago
CollaboratorOTHER
Washington University School of Medicine
CollaboratorOTHER
University of Michigan
CollaboratorOTHER
Duke Health
CollaboratorOTHER
University of Texas Southwestern Medical Center
CollaboratorOTHER
Alberta Children's Hospital
CollaboratorOTHER
British Columbia Children's Hospital
CollaboratorOTHER
The Hospital for Sick Children
CollaboratorOTHER
The University of Texas Health Science Center, Houston
CollaboratorOTHER
Children's Hospital Colorado
CollaboratorOTHER
Connecticut Children's Medical Center
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Months to 25 Years
Healthy volunteers
No

Inclusion criteria

* Participants will be followed in a participating institution's intestinal rehabilitation program * Participants will have a diagnosis of intestinal failure due to functional or structural intestinal dysfunction with current or prior history of specialized nutritional support (parenteral nutrition requirement for 60 out of 74 consecutive days) * Participants will be age 6 months to 25 years old. * Parents/caregivers must be able to complete questionnaire without assistance. * English or Spanish speaking

Exclusion criteria

* Participants aged less than 6 months or greater than 25 years will not be included in this study * Participants will not be enrolled less than 3 months from index admission or initial outpatient evaluation * Participants will not be enrolled less than 1 month from inpatient admission (any admission greater than 24 hours in duration) * Participants will not be enrolled less than 1 month from any operative intervention requiring general anesthesia. * Primary language other than English or Spanish. * Participants who have a currently functional small bowel, liver/small bowel or multivisceral transplant * While other major co-morbidities may be excluded at a later time during data analysis, or may be analyzed as a specific sub-group, they will not be excluded outright. For example, participants with global developmental delay may have parent surveys only, and therefore would need to be excluded from paired analysis of proxy vs. participant perception of HRQOL

Design outcomes

Primary

MeasureTime frameDescription
Health-related quality of life (hrQOL)BaselinehrQOL as determined by PedsQL Generic Core at time of enrollment and corrected for time from onset of disease
Health-related quality of life (hrQOL) Change over timeTrend over 5 yearshrQOL as determined by PedsQL Generic Core, assessed annually, looking at trend in change over 5 years of assessment and corrected for time from onset of disease
Disease-specific Health-related quality of life (hrQOL)BaselineDisease-specific hrQOL as determined by PedsQL GI Symptoms Scale at time of enrollment and corrected for time from onset of disease

Secondary

MeasureTime frameDescription
Family ImpactBaselineFamily impact as determined by the PedsQL Family Impact Module

Countries

Canada, United States

Contacts

CONTACTBiren P Modi, MD MPH
biren.modi@childrens.harvard.edu857-218-4651
PRINCIPAL_INVESTIGATORPatrick J Javid, MD

Seattle Children's Hospital

PRINCIPAL_INVESTIGATORBiren P Modi, MD MPH

Boston Children's Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026